Edilene Oliveira Silva

Dr. Edilene Oliveira Silva

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2011 in Cell Biology International
Verified
Journal Article
Closed access
PDF file
ARAna Paula Drummond Rodrigues
Ana Paula Drummond Rodrigues
ACAntônio Sergio C. Carvalho
Antônio Sergio C. Carvalho
ASAlberdan S. Santos
Alberdan S. Santos
CAClaudio Alves
Claudio Alves
JNJosé Luiz M. Do Nascimento
José Luiz M. Do Nascimento
ESEdilene Oliveira Silva
Edilene Oliveira Silva

7 July 2014 in Molecules
Verified
Journal Article
Open access
PDF file
CLCarlyle Lima
Carlyle Lima
José Rogério A. SilvaJosé Rogério A. Silva
José Rogério A. Silva
ECErica Cardoso
Erica Cardoso
ESEdilene Oliveira Silva
Edilene Oliveira Silva
JLJeronimo Lameira
Jeronimo Lameira
CAClaudio Alves
Claudio Alves
Tyrosinase is a key enzyme in melanin synthesis and widely distributed in plants and animals tissues. In mammals, this enzyme is related to pigment production, involved in wound healing, primary immune response and it can also contribute to catecholamines synthesis in the brain. Consequently, tyrosinase enzyme represents an attractive and selective target in the field of the medicine, cosmetics and bio-insecticides. In this paper, experimental kinetics and computational analysis were used to study the inhibition of tyrosinase by analogous of Kojic acid. The main interactions occurring between inhibitors-tyrosinase complexes and the influence of divalent cation (Cu2+) in enzymatic inhibition were investigated by using molecular docking, molecular dynamic simulations and electrostatic binding free energy by using the Linear Interaction Energy (LIE) method. The results showed that the electrostatic binding free energy are correlated with values of constant inhibition (r2 = 0.97).Thus, the model obtained here could contribute to future studies of this important system and, therefore, eventually facilitate development of tyrosinase inhibitors.

12 March 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ARAna Paula Drummond Rodrigues
Ana Paula Drummond Rodrigues
LFLuis Henrique S Farias
Luis Henrique S Farias
ACAntonio Sérgio C Carvalho
Antonio Sérgio C Carvalho
ASAlberdan S Santos
Alberdan S Santos
JNJosé Luiz M Do Nascimento
José Luiz M Do Nascimento
ESEdilene Oliveira Silva
Edilene Oliveira Silva
Kojic acid (KA) is a fungal metabolite used as a topical treatment skin-whitening cosmetic agent for melasma in humans; however its potential as an anti-leishmanial agent is unknown. Chemotherapy is one of the most effective treatments for Leishmaniasis. However, the drugs available are expensive, invasive, require long-term treatment and have severe side effects. Thus, the development of new effective leishmanicidal agents is a necessity. In this study we investigated the anti-leishmanial effect of KA on L. amazonensis, following in vitro and in vivo infections. KA (50 μg/mL) was found to decrease the growth by 62% (IC50 34 μg/mL) and 79% (IC50 27.84 μg/mL) of promastigotes and amastigotes in vitro, respectively. Ultrastructural analysis of KA-treated amastigotes showed the presence of vesicles bodies into the flagellar pocket, and an intense intracellular vacuolization and swelling of the mitochondrion. During the in vitro interaction of parasites and the host cell, KA reverses the superoxide anions (O2-) inhibitory mechanism promoted by parasite. In addition, 4 weeks after KA-topical formulation treatment of infected animals, a healing process was observed with a high production of collagen fibers and a decrease in parasite burden. Thus, these results demonstrated the great potential of KA as an anti-leishmanial compound.

27 July 2010 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
LGLeda R. C. Guimarães
Leda R. C. Guimarães
ARAna Paula Drummond Rodrigues
Ana Paula Drummond Rodrigues
PMPatrícia S. B. Marinho
Patrícia S. B. Marinho
AMAdolfo H. Muller
Adolfo H. Muller
GGGiselle M. S. Guilhon
Giselle M. S. Guilhon
ESEdilene Oliveira Silva
Edilene Oliveira Silva

24 July 2015 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
RSRaquel Raick P. da Silva
Raquel Raick P. da Silva
BSBruno J. M. da Silva
Bruno J. M. da Silva
ARAna Paula Drummond Rodrigues
Ana Paula Drummond Rodrigues
LFLuis Henrique S. Farias
Luis Henrique S. Farias
MSMilton da Silva
Milton da Silva
ESEdilene Oliveira Silva
Edilene Oliveira Silva
Leishmaniasis is an infectious disease caused by various species of the protozoan parasites of the Leishmania genus and transmitted by phlebotomine sandflies. The protozoa multiply in phagocytic cells, mainly macrophages, which play an important role defending the organism from pathogens. The most effective treatment for leishmaniasis is the chemotherapy and besides the high cost, these drugs are toxic and require a long period of treatment. Currently, some herbal products are considered an important alternative source of a new leishmanicidal agent, which includes the plant Physalis angulata, . We evaluated effects of an aqueous extract from roots of Physalis angulata (AEPa) on Leishmania proliferation, morphology and also determined whether physalins were present in the extract contributing to the knowledge of its pharmacological efficacy. Morphological alterations were determined by light microscopy, transmission and scanning electron microscopy. Host cell viability was evaluated by MTT, and propidium iodide. AEPa were submitted in full HRESITOF analysis. AEPa promoted a dose-dependent reduction on promastigotes (IC50 = 39.5 μg/mL ± 5.1) and amastigotes (IC50 = 43.4 μg/mL ± 10.1) growth. This growth inhibition was associated with several morphological alterations observed in promastigote forms. No cytotoxic effect in mammalian cells was detected (IC50 > 4000 μg/mL). Furthemore, the presence of physalins A, B, D, E, F, G and H were described, for the first time, in the P. angulata root. Results demonstrate that AEPa effectively promotes antileishmanial activity with several important morphological alterations and has no cytotoxic effects on host cells.

30 April 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
LFLindalva Maria de Meneses Costa Ferreira
Lindalva Maria de Meneses Costa Ferreira
YMYuri Yoshioka Modesto
Yuri Yoshioka Modesto
PQPoliana Queiroz-Souza
Poliana Queiroz-Souza
FNFabiana Cristina de Araújo Nascimento
Fabiana Cristina de Araújo Nascimento
RPRayanne Rocha Pereira
Rayanne Rocha Pereira
RCRoseane Maria Ribeiro Costa
Roseane Maria Ribeiro Costa
Hydrogels consist of a network of highly porous polymeric chains with the potential for use as a wound dressing. Propolis is a natural product with several biological properties including anti-inflammatory, antibacterial and antioxidant activities. This study was aimed at synthesizing and characterizing a polyacrylamide/methylcellulose hydrogel containing propolis as an active ingredient, to serve as a wound dressing alternative, for the treatment of skin lesions. The hydrogels were prepared using free radical polymerization, and were characterized using scanning electron microscopy, infrared spectroscopy, thermogravimetry, differential scanning calorimetry, swelling capacity, mechanical and rheological properties, UV-Vis spectroscopy, antioxidant activity by the DPPH, ABTS and FRAP assays and biocompatibility determined in Vero cells and J774 macrophages by the MTT assay. Hydrogels showed a porous and foliaceous structure with a well-defined network, a good ability to absorb water and aqueous solutions simulating body fluids as well as desirable mechanical properties and pseudoplastic behavior. In hydrogels containing 1.0 and 2.5% propolis, the contents of total polyphenols were 24.74 ± 1.71 mg GAE/g and 32.10 ± 1.01 mg GAE/g and those of total flavonoids 8.01 ± 0.99 mg QE/g and 13.81 ± 0.71 mg QE/g, respectively, in addition to good antioxidant activity determined with all three methods used. Therefore, hydrogels containing propolis extract, may serve as a promising alternative wound dressing for the treatment of skin lesions, due to their anti-oxidant properties, low cost and availability.